Serum trypsin as an early predictor of post-endoscopic retrograde pancreatography pancreatitis

Serum trypsin as an early predictor of post-endoscopic retrograde pancreatography pancreatitis - Serum trypsin as an early predictor of post-endoscopic retrograde pancreatography pancreatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053314

Enrollment

150

Registered

2024-01-10

Start date

2022-04-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients who wil be plaining to undergo ERCP

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: they were aged over 20 years and they had intact papilla, defined as the absence of previous sphincterotomy, papillary balloon dilation, or pancreaticobiliary stenting.

Exclusion criteria

Exclusion criteria: they had acute pancreatitis, defined as two of the following three features: (1) abdominal pain consistent with acute pancreatitis (acute onset of persistent, severe, epigastric pain often radiating to the back); (2) pancreatic enzyme activity at least the upper limit of normal; and (3) characteristic findings of acute pancreatitis on computed tomography(CT), magnetic resonance imaging or transabdominal ultrasound

Design outcomes

Primary

Measure	Time frame
the diagnostic ability of serum of tripsin levels immediately after (0h-TRY) and 2 hours after (2h-TRY) ERCP to predict PEP.	—

Countries

Japan

Contacts

Public ContactTakashi Tamura

Wakayama Medical University Second Departmet of Internal Medicine

ttakashi@wakayama-med.ac.jp0734472300

Outcome results